Table 2.
4G/4G and 4G/5G Genotypes | 5G/5G Genotype | P Value | |
---|---|---|---|
n | 85 | 26 | |
Age, yr* | 56.5 ± 19.6 | 50.6 ± 18.4 | 0.15 |
Gender, male (%) | 35 (41%) | 7 (27%) | 0.21 |
Race | |||
European descent | 64 (75%) | 20 (77%) | 0.15 |
African descent | 5 (6%) | 4 (15%) | |
Asian descent | 10 (12%) | 0 (0%) | |
Other | 6 (7%) | 2 (8%) | |
Ethnicity, Hispanic (%) | 8 (10%) | 10 (38%) | 0.001 |
Physiological characteristics† | |||
APACHE II | 20 (15–25) | 18 (16–26) | 0.56 |
SAPS II | 40 (30–55) | 40 (30–47) | 0.39 |
PF ratio | 165 (109–212) | 145 (119–183) | 0.35 |
Minimum PF ratio < 300 | 82 (96%) | 24 (92%) | 0.88 |
Comorbidities | |||
Sepsis | 18 (21%) | 5 (19%) | 0.8 |
Septic shock | 9 (11%) | 3 (12%) | 0.9 |
NYHA category 3 or greater | 8 (9%) | 0 (0%) | 0.1 |
Mean ± SD.
Median (25th–75th percentile).
APACHE II = acute physiology and chronic health evalution score; NYHA = New York Heart Association; PF = PaO2/FIO2; SAPS = simplified acute physiology score.